280 related articles for article (PubMed ID: 2528845)
21. Thrombin generation in patients with thrombotic thrombocytopenic purpura.
Takahashi H; Tatewaki W; Wada K; Shibata A
Am J Hematol; 1989 Dec; 32(4):255-7. PubMed ID: 2479264
[TBL] [Abstract][Full Text] [Related]
22. Thrombin and plasmin generation in patients with liver disease.
Takahashi H; Tatewaki W; Wada K; Yoshikawa A; Shibata A
Am J Hematol; 1989 Sep; 32(1):30-5. PubMed ID: 2527002
[TBL] [Abstract][Full Text] [Related]
23. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
24. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
[TBL] [Abstract][Full Text] [Related]
25. The imbalance between coagulation and fibrinolysis is related to the severity of the illness and the prognosis in sepsis.
Park KJ; Kim HJ; Hwang SC; Lee SM; Lee YH; Hahn MH; Kim SK; Lee WY
Korean J Intern Med; 1999 Jul; 14(2):72-7. PubMed ID: 10461428
[TBL] [Abstract][Full Text] [Related]
26. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
27. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
[TBL] [Abstract][Full Text] [Related]
28. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
[TBL] [Abstract][Full Text] [Related]
29. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis.
van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Bleichrodt RP
Br J Surg; 1996 Aug; 83(8):1133-5. PubMed ID: 8869327
[TBL] [Abstract][Full Text] [Related]
30. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia.
Baars JW; de Boer JP; Wagstaff J; Roem D; Eerenberg-Belmer AJ; Nauta J; Pinedo HM; Hack CE
Br J Haematol; 1992 Oct; 82(2):295-301. PubMed ID: 1419810
[TBL] [Abstract][Full Text] [Related]
32. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
Kanamori N; Koiwa F; Uda S
Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
[No Abstract] [Full Text] [Related]
33. Transient increase of plasma lipoprotein(a) in patients with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis?
Oshima S; Uchida K; Yasu T; Uno K; Nonogi H; Haze K
Arterioscler Thromb; 1991; 11(6):1772-7. PubMed ID: 1834167
[TBL] [Abstract][Full Text] [Related]
34. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
Hayashi M; Hamada Y; Ohkura T
Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
[No Abstract] [Full Text] [Related]
35. Changes in peritoneal coagulation and fibrinolysis after discontinuation of chronic peritoneal dialysis.
Homma S; Masunaga Y; Kurosu M; Inoue M; Sakurai T; Asano Y
Perit Dial Int; 2002; 22(2):178-83. PubMed ID: 11990401
[TBL] [Abstract][Full Text] [Related]
36. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
Hryszko T; Malyszko J; Malyszko JS; Brzosko S; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2001 Aug; 16(8):1692-6. PubMed ID: 11477176
[TBL] [Abstract][Full Text] [Related]
37. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
38. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
39. Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
Nagai T
J Atheroscler Thromb; 1994; 1(1):37-40. PubMed ID: 9222867
[TBL] [Abstract][Full Text] [Related]
40. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
Mustonen P; Lepäntalo M; Lassila R
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):244-9. PubMed ID: 9484989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]